Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children
Status:
Completed
Trial end date:
2018-06-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to select the optimal formulation of the norovirus vaccine from
different concentrations of virus-like particles (VLP) combined with aluminum hydroxide for
further development in children.